RemeGen
- Biotech or pharma, therapeutic R&D
RemeGen is a public commercial-stage innovative biotech headquartered in China with R&D facilities in U.S. We are commited to the discovery, development and commercialization of biologics with focused areas in autoimmune, oncology and ophthalmology